Where does MeiraGTX UK II Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), MeiraGTX UK II Limited ranks #36,446 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does MeiraGTX UK II Limited hold?

MeiraGTX UK II Limited holds 7 US utility patents granted between 2019 and 2025, spanning 5 technology areas.

What is MeiraGTX UK II Limited's Innovation Score?

MeiraGTX UK II Limited has an Innovation Score of 50.1 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is MeiraGTX UK II Limited's patent grant rate increasing or decreasing?

MeiraGTX UK II Limited's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for MeiraGTX UK II Limited's patents?

MeiraGTX UK II Limited's patents average 26.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the MeiraGTX UK II Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

MeiraGTX UK II Limited

Q: What technology areas does MeiraGTX UK II Limited focus on?

MeiraGTX UK II Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 7 patents, ranking #1,382 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Meiragtx ranks #36,446 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#36,446
of 49,997 US assignees by volume: Top 14%
by Innovation Score (50.1/100): 26.1
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36446 · Foreign Corporation #36,446 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,446/49,997
PHOTO-FINISH Media Cart Holdings
CPC-NARROW C12N · 5 areas
INNOV-PAR 50.1/100
CLAIMS-DENSE 26.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Media Cart Holdings, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Meiragtx’s 50.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (14%) Velocity 20.0 pts (40%) Breadth 7.9 pts (16%) Claim depth 15.0 pts (30%)

Qualcomm Incorporated · highest

85
MeiraGTX UK II · this assignee

50
3D Lighting… · lowest

7

What this shows Meiragtx's Innovation Score is 50.1/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Meiragtx?

Each dot is one of Meiragtx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Meiragtx’s own 26.1 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Meiragtx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Meiragtx's grants concentrate

MeiraGTX UK II Limited is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2019. By volume, Meiragtx sits between Media Cart Holdings, Inc. and Mercy Medical Research Institute.

Meiragtx's three-year grant acceleration

MeiraGTX UK II Limited shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Media Cart Holdin…

7
Mediaport Enterta…

7
Mediplus

7
Medlmmune

7
Melchor Gabilondo

7
Menlo Microsystems

7
Menlo Systems

7
Mercy Medical Res…

7
Meiragtx UK II ◀

7

What this shows MeiraGTX holds 7 patents at rank #36,492, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near MeiraGTX

By rank, the assignees closest to #36,492 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in MeiraGTX's primary technology class.

Meiragtx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

MeiraGTX UK II Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	14.3%
2022	3	42.9%
2023	2	28.6%
2025partial year	1	14.3%

Which technologies does MeiraGTX UK II Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C12Y - Enzymes 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

MeiraGTX UK II Limited's patent record in context - here's where to go next.

MeiraGTX UK II Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #36,446 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare MeiraGTX UK II Limited against Media Cart Holdings, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.